Simulation of multiple ion channel block provides improved early prediction of compounds' clinical torsadogenic risk.

AIMS: The level of inhibition of the human Ether-à-go-go-related gene (hERG) channel is one of the earliest preclinical markers used to predict the risk of a compound causing Torsade-de-Pointes (TdP) arrhythmias. While avoiding the use of drugs with maximum therapeutic concentrations within 30-fold...

Description complète

Détails bibliographiques
Auteurs principaux: Mirams, G, Cui, Y, Sher, A, Fink, M, Cooper, J, Heath, B, McMahon, N, Gavaghan, D, Noble, D
Format: Journal article
Langue:English
Publié: 2011
_version_ 1826305669220794368
author Mirams, G
Cui, Y
Sher, A
Fink, M
Cooper, J
Heath, B
McMahon, N
Gavaghan, D
Noble, D
author_facet Mirams, G
Cui, Y
Sher, A
Fink, M
Cooper, J
Heath, B
McMahon, N
Gavaghan, D
Noble, D
author_sort Mirams, G
collection OXFORD
description AIMS: The level of inhibition of the human Ether-à-go-go-related gene (hERG) channel is one of the earliest preclinical markers used to predict the risk of a compound causing Torsade-de-Pointes (TdP) arrhythmias. While avoiding the use of drugs with maximum therapeutic concentrations within 30-fold of their hERG inhibitory concentration 50% (IC(50)) values has been suggested, there are drugs that are exceptions to this rule: hERG inhibitors that do not cause TdP, and drugs that can cause TdP but are not strong hERG inhibitors. In this study, we investigate whether a simulated evaluation of multi-channel effects could be used to improve this early prediction of TdP risk. METHODS AND RESULTS: We collected multiple ion channel data (hERG, Na, L-type Ca) on 31 drugs associated with varied risks of TdP. To integrate the information on multi-channel block, we have performed simulations with a variety of mathematical models of cardiac cells (for rabbit, dog, and human ventricular myocyte models). Drug action is modelled using IC(50) values, and therapeutic drug concentrations to calculate the proportion of blocked channels and the channel conductances are modified accordingly. Various pacing protocols are simulated, and classification analysis is performed to evaluate the predictive power of the models for TdP risk. We find that simulation of action potential duration prolongation, at therapeutic concentrations, provides improved prediction of the TdP risk associated with a compound, above that provided by existing markers. CONCLUSION: The suggested calculations improve the reliability of early cardiac safety assessments, beyond those based solely on a hERG block effect.
first_indexed 2024-03-07T06:36:20Z
format Journal article
id oxford-uuid:f7c85a24-cb5a-496e-9dc4-717c1a9d93f3
institution University of Oxford
language English
last_indexed 2024-03-07T06:36:20Z
publishDate 2011
record_format dspace
spelling oxford-uuid:f7c85a24-cb5a-496e-9dc4-717c1a9d93f32022-03-27T12:45:08ZSimulation of multiple ion channel block provides improved early prediction of compounds' clinical torsadogenic risk.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:f7c85a24-cb5a-496e-9dc4-717c1a9d93f3EnglishSymplectic Elements at Oxford2011Mirams, GCui, YSher, AFink, MCooper, JHeath, BMcMahon, NGavaghan, DNoble, D AIMS: The level of inhibition of the human Ether-à-go-go-related gene (hERG) channel is one of the earliest preclinical markers used to predict the risk of a compound causing Torsade-de-Pointes (TdP) arrhythmias. While avoiding the use of drugs with maximum therapeutic concentrations within 30-fold of their hERG inhibitory concentration 50% (IC(50)) values has been suggested, there are drugs that are exceptions to this rule: hERG inhibitors that do not cause TdP, and drugs that can cause TdP but are not strong hERG inhibitors. In this study, we investigate whether a simulated evaluation of multi-channel effects could be used to improve this early prediction of TdP risk. METHODS AND RESULTS: We collected multiple ion channel data (hERG, Na, L-type Ca) on 31 drugs associated with varied risks of TdP. To integrate the information on multi-channel block, we have performed simulations with a variety of mathematical models of cardiac cells (for rabbit, dog, and human ventricular myocyte models). Drug action is modelled using IC(50) values, and therapeutic drug concentrations to calculate the proportion of blocked channels and the channel conductances are modified accordingly. Various pacing protocols are simulated, and classification analysis is performed to evaluate the predictive power of the models for TdP risk. We find that simulation of action potential duration prolongation, at therapeutic concentrations, provides improved prediction of the TdP risk associated with a compound, above that provided by existing markers. CONCLUSION: The suggested calculations improve the reliability of early cardiac safety assessments, beyond those based solely on a hERG block effect.
spellingShingle Mirams, G
Cui, Y
Sher, A
Fink, M
Cooper, J
Heath, B
McMahon, N
Gavaghan, D
Noble, D
Simulation of multiple ion channel block provides improved early prediction of compounds' clinical torsadogenic risk.
title Simulation of multiple ion channel block provides improved early prediction of compounds' clinical torsadogenic risk.
title_full Simulation of multiple ion channel block provides improved early prediction of compounds' clinical torsadogenic risk.
title_fullStr Simulation of multiple ion channel block provides improved early prediction of compounds' clinical torsadogenic risk.
title_full_unstemmed Simulation of multiple ion channel block provides improved early prediction of compounds' clinical torsadogenic risk.
title_short Simulation of multiple ion channel block provides improved early prediction of compounds' clinical torsadogenic risk.
title_sort simulation of multiple ion channel block provides improved early prediction of compounds clinical torsadogenic risk
work_keys_str_mv AT miramsg simulationofmultipleionchannelblockprovidesimprovedearlypredictionofcompoundsclinicaltorsadogenicrisk
AT cuiy simulationofmultipleionchannelblockprovidesimprovedearlypredictionofcompoundsclinicaltorsadogenicrisk
AT shera simulationofmultipleionchannelblockprovidesimprovedearlypredictionofcompoundsclinicaltorsadogenicrisk
AT finkm simulationofmultipleionchannelblockprovidesimprovedearlypredictionofcompoundsclinicaltorsadogenicrisk
AT cooperj simulationofmultipleionchannelblockprovidesimprovedearlypredictionofcompoundsclinicaltorsadogenicrisk
AT heathb simulationofmultipleionchannelblockprovidesimprovedearlypredictionofcompoundsclinicaltorsadogenicrisk
AT mcmahonn simulationofmultipleionchannelblockprovidesimprovedearlypredictionofcompoundsclinicaltorsadogenicrisk
AT gavaghand simulationofmultipleionchannelblockprovidesimprovedearlypredictionofcompoundsclinicaltorsadogenicrisk
AT nobled simulationofmultipleionchannelblockprovidesimprovedearlypredictionofcompoundsclinicaltorsadogenicrisk